Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 23;11(7):1796.
doi: 10.3390/biomedicines11071796.

Cognitive Alterations in Addictive Disorders: A Translational Approach

Affiliations
Review

Cognitive Alterations in Addictive Disorders: A Translational Approach

Ani Gasparyan et al. Biomedicines. .

Abstract

The cognitive decline in people with substance use disorders is well known and can be found during both the dependence and drug abstinence phases. At the clinical level, cognitive decline impairs the response to addiction treatment and increases dropout rates. It can be irreversible, even after the end of drug abuse consumption. Improving our understanding of the molecular and cellular alterations associated with cognitive decline could be essential to developing specific therapeutic strategies for its treatment. Developing animal models to simulate drug abuse-induced learning and memory alterations is critical to continue exploring this clinical situation. The main aim of this review is to summarize the most recent evidence on cognitive impairment and the associated biological markers in patients addicted to some of the most consumed drugs of abuse and in animal models simulating this clinical situation. The available information suggests the need to develop more studies to further explore the molecular alterations associated with cognitive impairment, with the ultimate goal of developing new potential therapeutic strategies.

Keywords: animal models; cognition; human studies; memory and learning; molecular changes; substance abuse.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 2
Figure 2
A summary of the molecular alterations associated with cognitive decline in patients with substance use disorders. 5HTT: serotonin transporter; 5HTTLPR: 5HTT gene polymorphic region; 5HT2A: serotonergic receptor 2A; BDNF: brain-derived neurotrophic factor; COMT: catechol-o-methyltransferase gene; CPu: caudate putamen; D2: dopaminergic receptor 2; D3: dopaminergic receptor 3; DLPFC: dorsolateral prefrontal cortex; DYN: dynorphin; HIPP: hippocampus; KOR: kappa opioid receptor; OFC: orbitofrontal cortex; PDYN: prodynorphin; SNP: single nucleotide polymorphism.
Figure 1
Figure 1
Main cognitive deficits observed in humans with alcohol use disorder, cannabis use disorder, cocaine use disorder, and opioid use disorder.

References

    1. APA . Diagnostic and Statistical Manual of Mental Disorders 5th edn. DSM-V. American Psychiatric Association (APA); Washington, DC, USA: 2013.
    1. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47((Suppl. 1)):33–46. doi: 10.1016/j.neuropharm.2004.06.025. - DOI - PubMed
    1. Morie K.P., DeVito E.E., Potenza M.N., Worhunsky P.D. Longitudinal changes in network engagement during cognitive control in cocaine use disorder. Drug. Alcohol. Depend. 2021;229:109151. doi: 10.1016/j.drugalcdep.2021.109151. - DOI - PMC - PubMed
    1. Bell M.D., Pittman B., Petrakis I., Yoon G. Donepezil and cognitive remediation therapy to augment treatment of alcohol use disorder related mild cognitive impairment (AUD-MCI): An open label pilot study with historical controls. Subst. Abus. 2021;42:412–416. doi: 10.1080/08897077.2020.1844847. - DOI - PubMed
    1. Murphy P., Garavan H. Cognitive predictors of problem drinking and AUDIT scores among college students. Drug. Alcohol. Depend. 2011;115:94–100. doi: 10.1016/j.drugalcdep.2010.10.011. - DOI - PubMed

LinkOut - more resources